The company's expansion into personalized treatments and wei...
The company's expansion into personalized treatments and weight-loss drugs, along with its positive net income forecast, has been positively received by the market. However, its success may depend on its ability to continue attracting users and expanding its product offerings.
Hims & Hers' Stock Jumps on Hopes of a First Profitable Year, as It Floats Opportunities in Weight Loss
Disclaimer: The above information does not represent the views of Moomoo Technologies Inc. (MTI) or constitute investment advice related to MTI and its affiliates.
Read more
Comment
Sign in to post a comment